Ipsen (XPAR:IPN) Accumulated Depreciation : €-617 Mil (As of Dec. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Ipsen Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Ipsen's quarterly accumulated depreciation declined from Dec. 2023 (€-556 Mil) to Jun. 2024 (€0 Mil) but then increased from Jun. 2024 (€0 Mil) to Dec. 2024 (€-617 Mil).

Ipsen's annual accumulated depreciation increased from Dec. 2022 (€0 Mil) to Dec. 2023 (€-556 Mil) and increased from Dec. 2023 (€-556 Mil) to Dec. 2024 (€-617 Mil).

Ipsen Accumulated Depreciation Historical Data

The historical data trend for Ipsen's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipsen Accumulated Depreciation Chart

Ipsen Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

Get a 7-Day Free Trial

-549.80

-642.50

-555.60

-616.90

Ipsen Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Accumulated Depreciation	Get a 7-Day Free Trial															-	-518.00	-555.60	-	-616.90

Ipsen Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Ipsen Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Ipsen's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipsen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipsen SA (XPAR:IPN) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

IPSEY:USA IPSEF:USA IPNp:UK 0MH6:UK I7G0:Germany IPN:Austria

Address

70 rue Balard, Paris, FRA, 75015

Website

https://www.ipsen.com

Ipsen is a global biotechnology company headquartered in France that develops and commercializes medicines across three therapeutic areas: oncology, neuroscience, and rare diseases. Ipsen was founded in 1929 as a consumer healthcare company focused on prescription-based products for digestive disorders and neurological disorders. Over the past nearly 100 years, Ipsen has shifted its focus to specialty care, which comprises the vast majority of its total revenue. In February 2022, Ipsen announced the divestment of its consumer healthcare business, which accounted for 8% of 2021 revenue. Ipsen has a large global footprint and sells more than 25 drugs in 115 countries.